Exited position

Ray Dalio’s Amn Healthcare Svcs Inc (AMN) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2021Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares241.05KHighest verified quarter-end share count
Quarters reported14Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Amn Healthcare Svcs Inc in Q2 2021. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Bridgewater Associates, LP sold the entire position in Q4 2024, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q4 2024
Sold the entire position−15.06K shares · No shares reported at quarter-end
Q3 2024
Sold 80.6% of the position−62.72K shares · 15.06K shares remained
Filing context

Quarter-end price $42.39 · Estimated holding basis $92.20

Q2 2024
Sold 63.9% of the position−137.71K shares · 77.78K shares remained
Filing context

Quarter-end price $51.23 · Estimated holding basis $92.20

Q1 2024
Sold 10.6% of the position−25.55K shares · 215.50K shares remained
Filing context

Quarter-end price $62.51 · Estimated holding basis $92.20

Q4 2023
Bought 12.2% more+26.30K shares · 241.05K shares reported after the change
Filing context

Quarter-end price $74.88 · Estimated holding basis $92.20

Q3 2023
Bought 126.0% more+119.73K shares · 214.75K shares reported after the change
Filing context

Quarter-end price $85.18 · Estimated holding basis $94.32

Portfolio importance

How important was Amn Healthcare Svcs Inc in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q3 2024
Last reported rank#664of 773 reported positions
Peak portfolio weight0.1%Q3 2023
Best historical rank#144Q3 2023
At peak importanceQ3 2023
AMN
0.1%
Largest holding
5.5%
Cross-investor discovery

Who else owns Amn Healthcare Svcs Inc?

Also reported by 1 other tracked investor in their latest verified filings.

Joel GreenblattGotham Asset Management
AMN0.0% of reported portfolio
Explore Amn Healthcare Svcs Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$34.262026-09-18

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.